Loading
Physician-scientist and cancer metabolism expert who directs MIT's Koch Institute for Integrative Cancer Research.
Matthew Vander Heiden is Director of the Koch Institute for Integrative Cancer Research at MIT, with scientific, strategic and operational oversight of the institute. His laboratory studies how cell metabolism supports tumour growth, and he is a practising medical oncologist at Dana-Farber Cancer Institute. His 2009 Science review on the Warburg effect is one of the most cited papers in the field.
| Title | Journal | Year |
|---|---|---|
| Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation | Science | 2009 |
Shares David H. Koch Institute for Integrative Cancer Research at MIT and the tag clinician-scientist.
Shares Pancreatic ductal adenocarcinoma and the tags leadership, clinician-scientist.
Shares Pancreatic ductal adenocarcinoma and the tags leadership, clinician-scientist.
Shares Pancreatic ductal adenocarcinoma and the tags leadership, clinician-scientist.
Shares Pancreatic ductal adenocarcinoma and the tags leadership, clinician-scientist.
Shares Pancreatic ductal adenocarcinoma and the tags leadership, clinician-scientist.
Shares the tags leadership, clinician-scientist.
Shares the tags leadership, clinician-scientist.